INS and metabolic syndrome: Its use in rheumatoid arthritis is associated with a reduced risk for developing diabetes in large observational studies [39, 40], and its administration to healthy obese subjects without the metabolic syndrome increases the Matsuda index of insulin sensitivity [41].